LINC01679: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

Target Name: LINC01679

NCBI ID: G101928399

LINC01679

Other Name(s): long intergenic non-protein coding RNA 1679 | TCONS_00029157 | Long intergenic non-protein coding RNA 1679

LINC01679: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

LINC01679 is a long intergenic non-protein-coding RNA (lncRNA) that has been identified as a potential drug target and biomarker. It is a non-coding RNA molecule that is expressed in various tissues and cells of the human body. LINC01679 has been shown to play a role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation.

Drug Target Potential

LINC01679 has been identified as a potential drug target due to its unique structure and its expressed levels in various tissues. It is a long RNA molecule that has a length of approximately 290 nucleotides. It is expressed in various tissues of the human body, including the brain, heart, and liver. LINC01679 has been shown to play a role in the regulation of cellular processes that are crucial for human health.

One of the key features of LINC01679 is its unique structure. It is a non-coding RNA molecule that has a well- conserved structure that is similar to other non-coding RNAs. LINC01679 is characterized by the presence of a stem-loop region, a 5'-end region, and a 3'-end region. The stem-loop region is a loop-like structure that is located at the start of the RNA molecule. The 5'-end region is the region that is responsible for the termination of the RNA molecule. The 3'-end region is the region that is responsible for the start of the RNA molecule.

Another feature of LINC01679 is its expressed levels. It is expressed in various tissues of the human body, including the brain, heart, and liver. LINC01679 has been shown to play a role in the regulation of cellular processes that are crucial for human health. For example, LINC01679 has been shown to be involved in the regulation of cell apoptosis.

Biomarker Potential

LINC01679 has also been identified as a potential biomarker for various diseases. For example, LINC01679 has been shown to be involved in the regulation of cell apoptosis, which is a crucial process that helps the body to remove damaged or dysfunctional cells. LINC01679 has also been shown to be involved in the regulation of inflammation, which is a crucial process that helps the body to fight off harmful bacteria and viruses.

Conclusion

In conclusion, LINC01679 is a long intergenic non-protein-coding RNA that has been identified as a potential drug target and biomarker. Its unique structure and expressed levels make it a promising candidate for drug development. Further research is needed to fully understand the role of LINC01679 in cellular processes and its potential as a biomarker for various diseases.

Protein Name: Long Intergenic Non-protein Coding RNA 1679

The "LINC01679 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01679 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets